NDC 68229-502-01 - CopperFixx
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68229-502
- Requested NDC
- 68229-502-01
- Package NDCs from labels
- 68229-502-01, 68229-502-02
- Manufacturer
- Quest Products, Inc. | Filltech USA, LLC
- Effective date
- 2024-11-05
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| CopperFixx - Quest Products, Inc. | Filltech USA, LLC | Quest Products, Inc. | Filltech USA, LLC | 2024-11-05 | HUMAN OTC DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 68229-502-02 | 2021-08-20 | C162847 | 48780-1 | 9d75b9cf-e990-f424-e053-dadaa90a57ce | CopperFixx™ |
| 68229-502-02 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-e990-f424-e053-dadaa90a57ce | CopperFixx™ |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68229-502-01 | CopperFixx | 57 g in 1 JAR | OINTMENT | 57 | 7 | |
| 68229-502-02 | CopperFixx | 1 in 1 CARTON | OINTMENT | 1 | 7 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Antacid | ALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE AND SIMETHICONE | Safeway | d36b56a4-06f0-47ff-8add-4c327d60be22 | 2016-01-21 | Warnings | 92RU3N3Y1O |
| Gas Relief | SIMETHICONE | Safeway | 14a9fb00-707a-4b55-a060-82ad53a806e3 | 2016-01-08 | Warnings | 92RU3N3Y1O |
| Lactated Ringers | SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE | Baxter Healthcare Corporation | f09f80bf-2f8b-4420-865d-aec2d5e5cd4d | 2012-06-12 | TU7HW0W0QT |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.